Armata Pharmaceuticals (ARMP) FCF Margin (2013 - 2020)

Armata Pharmaceuticals has disclosed FCF Margin across 6 years of filings, most recently posting 13319.35% for Q2 2020.

• FCF Margin for Q2 2020 came in at 13319.35%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was 13433.33% (changed N/A YoY), and the FY2017 annual result was 8043.48%, down 385694.0% from the prior year.
• FCF Margin came in at 13319.35% for Q2 2020 at Armata Pharmaceuticals, down from 11935.0% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 1647.37% in Q3 2017 to a low of 13319.35% in Q2 2020.
• The 3-year median for FCF Margin is 10475.0% (2017), against an average of 8053.3%.
• Across the five-year window, FCF Margin tumbled 906928 bps in 2016 and surged 924918 bps in 2017, its largest moves.
• Armata Pharmaceuticals' FCF Margin stood at 6868.18% in 2016, then slumped by 74 bps to 11935.0% in 2017, then fell by 12 bps to 13319.35% in 2020.
• The last three FCF Margin figures came in at 13319.35% (Q2 2020), 11935.0% (Q4 2017), and 1647.37% (Q3 2017), per Business Quant data.